SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-028888
Filing Date
2022-10-19
Accepted
2022-10-19 16:31:18
Documents
19
Period of Report
2022-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 75727
2 ex2-1.htm EX-2.1 772020
3 ex10-1.htm EX-10.1 100910
4 ex10-2.htm EX-10.2 98797
5 ex99-1.htm EX-99.1 39911
6 ex99-2.htm EX-99.2 69101
7 ex99-1_001.jpg GRAPHIC 6482
8 ex99-2_001.jpg GRAPHIC 94236
  Complete submission text file 0001493152-22-028888.txt   1671220

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE adxsd-20221018.xsd EX-101.SCH 3227
10 XBRL LABEL FILE adxsd-20221018_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE adxsd-20221018_pre.xml EX-101.PRE 22358
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3329
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 221318933
SIC: 2834 Pharmaceutical Preparations